Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $69,493 | 34 | 92.5% |
| Food and Beverage | $3,472 | 58 | 4.6% |
| Travel and Lodging | $1,726 | 4 | 2.3% |
| Education | $475.00 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $69,968 | 35 | $0 (2024) |
| Allergan Inc. | $1,543 | 10 | $0 (2019) |
| DAVOL INC. | $1,129 | 4 | $0 (2018) |
| Merz North America, Inc. | $1,055 | 14 | $0 (2023) |
| Galderma Laboratories, L.P. | $340.77 | 4 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $234.07 | 3 | $0 (2018) |
| GlaxoSmithKline, LLC. | $158.42 | 5 | $0 (2017) |
| Baxter Healthcare | $145.37 | 1 | $0 (2024) |
| Shire North American Group Inc | $132.89 | 6 | $0 (2018) |
| AbbVie, Inc. | $117.98 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $11,912 | 6 | Takeda Pharmaceuticals U.S.A., Inc. ($11,767) |
| 2023 | $14,295 | 17 | Takeda Pharmaceuticals U.S.A., Inc. ($13,467) |
| 2022 | $29,250 | 19 | Takeda Pharmaceuticals U.S.A., Inc. ($28,940) |
| 2021 | $16,045 | 12 | Takeda Pharmaceuticals U.S.A., Inc. ($15,795) |
| 2019 | $1,397 | 9 | Allergan Inc. ($1,374) |
| 2018 | $1,416 | 16 | DAVOL INC. ($1,129) |
| 2017 | $851.80 | 18 | Boehringer Ingelheim Pharmaceuticals, Inc. ($215.60) |
All Payment Transactions
97 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,353.33 | General |
| 11/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,353.33 | General |
| 10/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,353.33 | General |
| 09/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,353.33 | General |
| 07/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,353.33 | General |
| 04/18/2024 | Baxter Healthcare | PERCLOT (Device) | Food and Beverage | In-kind items and services | $145.37 | General |
| Category: Surgical Care | ||||||
| 12/15/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,353.33 | General |
| 11/10/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,353.33 | General |
| 10/13/2023 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: Neuromodulation | ||||||
| 09/19/2023 | Galderma Laboratories, L.P. | DYSPORT (Biological) | Food and Beverage | In-kind items and services | $15.84 | General |
| 08/18/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $900.00 | General |
| 06/14/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,353.33 | General |
| 04/07/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,253.33 | General |
| 03/18/2023 | Merz North America, Inc. | Xeomin (Biological) | Food and Beverage | In-kind items and services | $300.00 | General |
| Category: Dermatology | ||||||
| 02/23/2023 | Merz North America, Inc. | — | Food and Beverage | In-kind items and services | $178.50 | General |
| 02/23/2023 | Merz North America, Inc. | — | Food and Beverage | In-kind items and services | $45.47 | General |
| 02/13/2023 | Merz North America, Inc. | — | Food and Beverage | In-kind items and services | $153.24 | General |
| 02/08/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,253.33 | General |
| 01/25/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| 01/07/2023 | Merz North America, Inc. | — | Food and Beverage | In-kind items and services | $24.13 | General |
| 01/05/2023 | Merz North America, Inc. | — | Food and Beverage | In-kind items and services | $41.62 | General |
| 01/05/2023 | Merz North America, Inc. | — | Food and Beverage | In-kind items and services | $24.87 | General |
| 01/05/2023 | Merz North America, Inc. | — | Food and Beverage | In-kind items and services | $23.56 | General |
| 12/21/2022 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| 12/07/2022 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,253.33 | General |
About Dr. Anne Ponce De Leon, MD
Dr. Anne Ponce De Leon, MD is a Family Medicine healthcare provider based in Sugar Land, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1083649743.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anne Ponce De Leon, MD has received a total of $75,166 in payments from pharmaceutical and medical device companies, with $11,912 received in 2024. These payments were reported across 97 transactions from 19 companies. The most common payment nature is "Consulting Fee" ($69,493).
Practice Information
- Specialty Family Medicine
- Location Sugar Land, TX
- Active Since 07/11/2006
- Last Updated 04/10/2019
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1083649743
Products in Payments
- ALLODERM (Device) $1,374
- Xeomin (Biological) $300.00
- STRATTICE (Device) $168.71
- PERCLOT (Device) $145.37
- JARDIANCE (Drug) $143.45
- Androgel (Drug) $117.98
- MYDAYIS (Drug) $114.09
- 4-K (Device) $108.56
- ANORO ELLIPTA (Drug) $91.99
- OFEV (Drug) $90.62
- SOLIQUA (Drug) $73.83
- ANORO (Drug) $43.90
- Hetlioz (Drug) $37.74
- NP Thyroid (Drug) $22.79
- SHINGRIX (Drug) $22.53
- TRULICITY (Drug) $21.31
- ETERNA (Device) $20.69
- TOUJEO (Drug) $19.35
- VYVANSE (Drug) $18.80
- DYSPORT (Biological) $15.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Sugar Land
Wilner Jeudy, Md, MD
Family Medicine — Payments: $243,277
Dr. Carl Meisner, Md, MD
Family Medicine — Payments: $116,479
Hammad Zaidi, M.d, M.D
Family Medicine — Payments: $49,687
John Vanderzyl, Md, MD
Family Medicine — Payments: $21,283
James Trippett, Md, MD
Family Medicine — Payments: $20,590
Dr. Dwayne Williams, Md, MD
Family Medicine — Payments: $20,043